Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA-approved lenses reduce childhood myopia progression by up to 70% over two years.
FDA-approved Essilor Stellest lenses, available in the U.S. since September, can slow myopia progression in children aged 6 to 12 by up to 70% over two years, according to manufacturer data.
The lenses feature 11 concentric rings with tiny raised dots that redirect light to reduce eye elongation, a key factor in worsening nearsightedness.
Myopia affects 30% to 40% of U.S. high school students, with rising rates linked to screen time and close-up work.
While the exact biological mechanism is still under study, the lenses offer a non-invasive option to reduce long-term risks like retinal detachment.
Priced at $450, they are expected to be partially covered by major vision insurance plans.
Independent research is ongoing to confirm results.
Los lentes aprobados por la FDA reducen la progresión de la miopía infantil hasta en un 70% durante dos años.